Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
BMC Surg ; 18(Suppl 1): 82, 2019 Apr 24.
Article in English | MEDLINE | ID: mdl-31074394

ABSTRACT

BACKGROUND: Currently, there is no strong evidence on the effectiveness and safety of pharmacological antithrombotic prophylaxis in thyroid surgery. The aim of this study was to establish whether the prophylactic use of low-molecular-weight heparin (LMWH) could negatively affect the early outcomes of patients undergoing total thyroidectomy. METHODS: Data from patients submitted to total thyroidectomy between February 2013 and October 2017 were retrospectively collected and analysed. Only patients with indication to antithrombotic prophylaxis according to current guidelines were included in the study. Eligible cases were divided into two groups, which corresponded to two distinct periods of our surgical practice: Group A, which included 178 consecutive patients who were submitted to antithrombotic prophylaxis with LMWH, and Group B, which included 348 consecutive patients who did not receive prophylaxis. Primary endpoints were the incidence of post-operative cervical haematomas (POCH) and thromboembolic events. Secondary endpoint was the length of postoperative hospital stay. Statistical analysis was performed by using Student's t test for continuous variables and Chi-square test for categorical variables. A P value of less than 0.05 was considered statistically significant. RESULTS: The two groups of patients were comparable in terms of age, gender, thyroid disease, duration of surgery, and weight of the thyroid gland. Overall, no thromboembolic events were registered. The comparative analysis of the other outcome measures, showed no significant differences between the two groups (POCH: 2 cases (1.12%) in Group A vs 8 cases (2.30%) in Group B - p 0.349; Postoperative hospital stay: 2.90 ± 0.86 days in Group A vs 2.89 ± 0.99 days in Group B - p 0.908). CONCLUSIONS: Data from this study do not support or contraindicate the use of antithrombotic prophylaxis in thyroid surgery. However, since thyroidectomy is a closed-space procedure, and even modest bleeding may quickly result in airway compression and death by asphyxia, mechanical prophylaxis should be preferred to LMWH whenever possible. TRIAL REGISTRATION: ISRCTN ISRCTN12029395. Registered 05/02/2018 retrospectively registered.


Subject(s)
Fibrinolytic Agents/administration & dosage , Heparin, Low-Molecular-Weight/administration & dosage , Thyroid Gland/surgery , Thyroidectomy/methods , Aged , Cohort Studies , Female , Hemorrhage/epidemiology , Humans , Length of Stay , Male , Middle Aged , Retrospective Studies
2.
Hernia ; 23(4): 801-807, 2019 08.
Article in English | MEDLINE | ID: mdl-30980199

ABSTRACT

PURPOSE: Mesh fixation and broad overlap represent an open issue in umbilical hernia repair. A proprietary-designed implant with tentacle straps at its boundary has been developed to ensure a suture-free repair and a broader coverage of the abdominal wall. The study describes the results of umbilical hernia procedures carried out with the tentacle-shaped implant and the related surgical technique. METHODS: A proprietary tentacle-shaped flat mesh having a central body with integrated radiating arms at its edge was used to repair large umbilical hernias in 62 patients. The implant was placed in preperitoneal sublay. The friction of the straps, crossing the abdominal wall thanks to a special needle passer, was intended to assure adequate grip to hold the implant in place assuring a fixation-free procedure and broad overlap of the hernia defect. RESULTS: In a mean follow-up of 48 months (range 10-62 months), 4 seromas and 2 ischemia of the navel skin occurred. No infections, hematomas, chronic pain, mesh dislocation, or recurrence has been reported. CONCLUSIONS: The tentacle strap system of the prosthesis effectively ensured an easier implant placement avoiding the need for suturing the mesh. The arms of the implant ensured a proper orientation and stabilization of the mesh in association with a broad defect overlap. The specifically developed surgical procedure showed a quick postoperative recovery, a very low complication rate, and no recurrences even in the long term.


Subject(s)
Hernia, Umbilical/surgery , Herniorrhaphy/methods , Prostheses and Implants , Surgical Mesh , Abdominal Wall/surgery , Adult , Aged , Female , Humans , Male , Middle Aged , Prosthesis Implantation/methods , Recurrence , Suture Techniques , Umbilicus/surgery
3.
G Chir ; 39(6): 378-382, 2018.
Article in English | MEDLINE | ID: mdl-30563602

ABSTRACT

Pseudoangiomatous stromal hyperplasia (PASH) is an uncommon benign mesenchymal breast lesion. There are extremely rare reports of PASH arising in accessory breast tissue. To date, in literature, fewer than 10 cases of PASH occurring in axillary region have been described. We report a case presenting as axillary lump in a young woman. A 20-year-old female presented to our surgical unit for a progressively growing and painful palpable mass of the right axilla for about a year. Before surgery an ultrasound was performed. The patient underwent local excision of the lesion under local anaesthesia. Through histological and immunohistochemical examination a pseudoangiomatous stromal hyperplasia (PASH) was diagnosed. At 6 months of followup the patient is free of disease. It is important to include PASH also in the differential diagnosis of axillary lumps. Histological examination of the surgical specimen and surgery represent, respectively, the mainstay for diagnosis and therapy.


Subject(s)
Angiomatosis/diagnosis , Axilla/pathology , Breast Diseases/diagnosis , Hyperplasia/diagnosis , Angiomatosis/etiology , Angiomatosis/pathology , Angiomatosis/surgery , Breast , Breast Diseases/etiology , Breast Diseases/pathology , Breast Diseases/surgery , Choristoma/complications , Contraceptives, Oral, Hormonal/adverse effects , Contraceptives, Oral, Hormonal/pharmacology , Diagnosis, Differential , Female , Gonadal Steroid Hormones/adverse effects , Hormone Replacement Therapy/adverse effects , Humans , Hyperplasia/etiology , Hyperplasia/pathology , Hyperplasia/surgery , Myofibroblasts/drug effects , Young Adult
4.
G Chir ; 39(1): 51-56, 2018.
Article in English | MEDLINE | ID: mdl-29549682

ABSTRACT

Primary thyroid leiomyosarcoma (LMS) is an extremely rare tumor. We report a case of a 47-year-old male with a rapidly growing neck mass and disfagia. Preoperative investigations were diagnostic of anaplastic carcinoma. Total thyroidectomy with partial esophagectomy and dissection of right infrahyoid muscles was performed. Through histolological and immunohistochemical evaluations a primary thyroid high-grade LMS was diagnosed. At 2 months of follow-up a local recurrence was detected and consequently the patient was submitted to chemotherapy with partial response. He is still alive 9 months after surgery. Diagnosis of primary thyroid LMS is difficult due to its similarity to other more common thyroid tumors. To date, there is no standard therapy and prognosis is poor.


Subject(s)
Leiomyosarcoma/surgery , Thyroid Neoplasms/surgery , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Combined Modality Therapy , Doxorubicin/administration & dosage , Esophagectomy/methods , Esophagus/pathology , Esophagus/surgery , Humans , Ifosfamide/administration & dosage , Leiomyosarcoma/diagnosis , Leiomyosarcoma/drug therapy , Leiomyosarcoma/pathology , Male , Middle Aged , Neoplasm Invasiveness , Neoplasm Recurrence, Local/drug therapy , Thyroid Neoplasms/diagnosis , Thyroid Neoplasms/drug therapy , Thyroid Neoplasms/pathology , Thyroidectomy
SELECTION OF CITATIONS
SEARCH DETAIL
...